Haleon (HLN) Operating Income Growth (1y) (2022 - 2023)

Haleon (HLN) Operating Income Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 25.63%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -1.30%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -319.32%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -14.89%
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 97.23%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 719.49%
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 21.25%
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 350.00%

Historic Data

Download Data
DateValue
Dec 31, 2023 24.26%
Dec 31, 2022 2.75%